Adult Vaccine Market Size, Share, Trends, Growth Outlook

Adult Vaccine Market is estimated to increase at a growth rate of 8.3% CAGR over the forecast period from 2024 to 2030.

The Adult Vaccine Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Monovalent, multivalent), By Application (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, COVID-19, Others), By Technology (Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others).

An Introduction to Adult Vaccine Market in 2024

The Adult Vaccine Market in 2024 is experiencing rapid growth, fueled by the increasing awareness of vaccine-preventable diseases, expanding immunization recommendations, and the growing emphasis on preventive healthcare strategies to reduce morbidity and mortality among adult populations. Vaccination plays a crucial role in protecting individuals against infectious diseases, including influenza, pneumococcal disease, and shingles, as well as vaccine-preventable cancers such as human papillomavirus (HPV)-related malignancies. With advancements in vaccine development, formulation technologies, and immunization delivery systems, the market offers a variety of adult vaccines, including seasonal flu vaccines, travel vaccines, and booster doses, tailored to specific age groups, risk factors, and healthcare settings. Moreover, the integration of vaccination registries, reminder systems, and vaccine hesitancy interventions further enhances vaccine uptake, coverage rates, and public health outcomes, driving market expansion and supporting disease prevention initiatives.

Adult Vaccine Market Trend: Increasing Emphasis on Preventive Healthcare and Immunization

A prominent trend in the Adult Vaccine market is the increasing emphasis on preventive healthcare and immunization among adults. With growing awareness about the importance of vaccination in preventing infectious diseases and reducing healthcare costs, there has been a shift towards promoting vaccination across all age groups, including adults. Public health campaigns, employer-sponsored vaccination programs, and government initiatives aimed at increasing adult immunization rates are driving the uptake of vaccines among the adult population. Moreover, the COVID-19 pandemic has highlighted the importance of vaccination in protecting against respiratory illnesses, leading to a heightened focus on adult vaccination as part of comprehensive public health strategies to control disease transmission and improve population health outcomes.

Adult Vaccine Market Driver: Aging Population and Expanded Vaccine Recommendations

The primary driver fueling the Adult Vaccine market is the aging population and expanded vaccine recommendations for adults. As the global population ages, there is a growing need to address the healthcare needs of older adults who are at increased risk of vaccine-preventable diseases and complications. Additionally, advances in medical research and vaccine development have led to the expansion of vaccine recommendations for adults, including vaccines for influenza, pneumococcal disease, shingles, and human papillomavirus (HPV). Public health authorities, healthcare providers, and vaccine manufacturers are actively promoting vaccination as a critical component of healthy aging and disease prevention, driving the demand for adult vaccines and contributing to market growth.

Adult Vaccine Market Opportunity: Integration of Adult Vaccination Services into Primary Care Settings

An opportunity in the Adult Vaccine market lies in the integration of adult vaccination services into primary care settings to enhance accessibility, convenience, and uptake of vaccines among adults. By incorporating vaccination into routine primary care visits, healthcare providers can streamline vaccine delivery, identify and address vaccination gaps, and ensure that adults receive recommended vaccines based on their age, health status, and risk factors. Additionally, leveraging electronic health records (EHRs) and reminder systems can facilitate vaccine tracking, documentation, and follow-up, enabling healthcare providers to monitor vaccination coverage and adherence to vaccine schedules. Furthermore, education and counseling provided during primary care visits can help address vaccine hesitancy, misconceptions, and concerns among adults, promoting informed decision-making and vaccine acceptance. By capitalizing on the existing infrastructure and patient-provider relationships in primary care settings, healthcare organizations can optimize adult vaccination services, improve vaccination rates, and contribute to better public health outcomes.

Adult Vaccine Market Segmentation

By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Adult Vaccine Market Companies

AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd

 

 

Reasons to Buy the Adult Vaccine Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Adult Vaccine Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Adult Vaccine Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Adult Vaccine Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Adult Vaccine Market Size Outlook, $ Million, 2021 to 2030
3.2 Adult Vaccine Market Outlook by Type, $ Million, 2021 to 2030
3.3 Adult Vaccine Market Outlook by Product, $ Million, 2021 to 2030
3.4 Adult Vaccine Market Outlook by Application, $ Million, 2021 to 2030
3.5 Adult Vaccine Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Adult Vaccine Market Industry
4.2 Key Market Trends in Adult Vaccine Market Industry
4.3 Potential Opportunities in Adult Vaccine Market Industry
4.4 Key Challenges in Adult Vaccine Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Adult Vaccine Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Adult Vaccine Market Outlook By Segments
7.1 Adult Vaccine Market Outlook by Segments
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

8 North America Adult Vaccine Market Analysis And Outlook To 2030
8.1 Introduction to North America Adult Vaccine Markets in 2024
8.2 North America Adult Vaccine Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Adult Vaccine Market size Outlook by Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

9 Europe Adult Vaccine Market Analysis And Outlook To 2030
9.1 Introduction to Europe Adult Vaccine Markets in 2024
9.2 Europe Adult Vaccine Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Adult Vaccine Market Size Outlook By Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

10 Asia Pacific Adult Vaccine Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Adult Vaccine Markets in 2024
10.2 Asia Pacific Adult Vaccine Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Adult Vaccine Market size Outlook by Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

11 South America Adult Vaccine Market Analysis And Outlook To 2030
11.1 Introduction to South America Adult Vaccine Markets in 2024
11.2 South America Adult Vaccine Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Adult Vaccine Market size Outlook by Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

12 Middle East And Africa Adult Vaccine Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Adult Vaccine Markets in 2024
12.2 Middle East and Africa Adult Vaccine Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Adult Vaccine Market size Outlook by Segments, 2021-2030
By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AstraZeneca
Bharat Biotech
Biological E Ltd
CSL Ltd
GSK plc
Indian Immunologicals Ltd
Johnson & Johnson Services Inc
Pfizer Inc
Sanofi
Serum Institute of India Pvt. Ltd

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Monovalent
multivalent
By Application
Influenza
Tetanus/Diphtheria/Pertussis
Varicella
Human Papillomavirus
Zoster
Measles/mumps/Rubella
Pneumococcal
Hepatitis
COVID-19
Others
By Technology
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others